Skip to main content
Log in

Nomogram for modification of dosage regimens in patients with chronic renal function impairment

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

A nomogram is presented for modifying dosage regimens of drugs administered to patients with chronic renal function impairment. The usefulness and limitations of the nomogram are discussed in terms of the objectives of dosage regimens. The nomogram is intended to serve as a guide for drug administration in patients with renal disease. It may be particularly helpful for drugs on which little or no definitive research has been undertaken.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. M. Rowland. Drug administration and regimens. In K. L. Melmon and A. F. Morelli (eds.),Clinical Pharmacology: Basic Principles in Therapeutics, Macmillan, New York (1972).

    Google Scholar 

  2. E. Krüger-Thiemer. Formal theory of drug dosage regimens.J. Theoret. Biol. 13: 212–235 (1966).

    Article  Google Scholar 

  3. J. G. Wagner. Theory and practice of adjusting dosage of drugs on the basis of endogenous creatine clearance or serum creatinine concentration. InBiopharmaceutics and Relevant Pharmacokinetics, Drug Intelligence Publications, Hamilton Press, Hamilton, Ill. (1971).

    Google Scholar 

  4. L. Dettli, P. Spring, and R. Habersang. Drug dosage in patients with impaired renal function.Postgrad. Med. J. 46 (October Suppl.): 32–35 (1970).

    Google Scholar 

  5. L. Dettli. Multiple dose elimination kinetics and drug accumulation in patients with normal and with impaired kidney function. In G. Raspe (ed.),Advances in the Biosciences 5, Schering Workshop on Pharmacokinetics, Berlin, 1969, Pergamon Press, London (1970).

    Google Scholar 

  6. B. M. Orme and R. E. Cutler. The relationship between kanamycin and pharmacokinetics: Distribution and renal function.Pharmacol. Therap. 19: 543–550 (1969).

    Google Scholar 

  7. R. E. Cutler and B. M. Orme. Correlation of serum creatinine concentration and kanamycin half-life.JAMA 209: 539–542 (1969).

    Article  CAS  PubMed  Google Scholar 

  8. J. Koch-Weser and S. W. Klein. Procainamide dosage schedules, plasma concentrations and clinical effects.JAMA 215: 1454–1460 (1971).

    Article  CAS  PubMed  Google Scholar 

  9. R. W. Jelliffe. An improved method of digoxin therapy.Ann. Int. Med. 69: 703–717 (1968).

    Article  CAS  PubMed  Google Scholar 

  10. A. Gyselynck, A. Forrey, and R. Cutler. Pharmacokinetics of gentamycin: Distribution and plasma and renal clearance.J. Infect. Dis. 124: S70 (1971).

    Article  CAS  PubMed  Google Scholar 

  11. R. H. Reuning, B. S. Sams, and R. E. Notari. Role of pharmacokinetics in drug dosage adjustment. I. Pharmacologic effect kinetics and apparent volume of distribution of digoxin.J. Clin. Pharmacol. 13: 127–136 (1973).

    CAS  Google Scholar 

  12. T. A. Hoffman, R. Cestero, and W. E. Bullock. Pharmacodynamics of carbenicillin in hepatic and renal failure.Ann. Int. Med. 73: 173–178 (1970).

    Article  CAS  PubMed  Google Scholar 

  13. J. Kampann, J. M. Hansen, K. Siersbock-Nielson, and H. Laursen. Effect of some drugs on penicillin half-life in blood.Clin. Pharmacol. Therap. 13: 516–519 (1972).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tozer, T.N. Nomogram for modification of dosage regimens in patients with chronic renal function impairment. Journal of Pharmacokinetics and Biopharmaceutics 2, 13–28 (1974). https://doi.org/10.1007/BF01062143

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01062143

Key words

Navigation